Lensar (LNSR) EPS (Basic) (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,400.00% |
| Dec 31, 2025 | 61.29% |
| Sep 30, 2025 | -106.67% |
| Jun 30, 2025 | 93.53% |
| Mar 31, 2025 | -43.21% |
| Dec 31, 2024 | -1,146.15% |
| Sep 30, 2024 | 83.54% |
| Jun 30, 2024 | -315.79% |
| Mar 31, 2024 | 45.71% |
| Dec 31, 2023 | -369.23% |
| Sep 30, 2023 | 116.05% |
| Jun 30, 2023 | -102.50% |
| Mar 31, 2023 | -73.91% |
| Dec 31, 2022 | 41.03% |
| Sep 30, 2022 | 41.79% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | -67.50% |
| Dec 31, 2021 | 38.46% |
| Sep 30, 2021 | -38.30% |
| Jun 30, 2021 | 16.07% |
| Mar 31, 2021 | -133.33% |
| Dec 31, 2020 | 62.50% |
| Sep 30, 2020 | 84.76% |
| Jun 30, 2020 | -22.09% |
| Mar 31, 2020 | -48.92% |
| Dec 31, 2019 | 57.54% |